Antifolate cancer drugs are: (PGI Nov 2009)
The correct answer here should be methotrexate. Methotrexate is a classic example of an antifolate. It inhibits DHFR, preventing the conversion of dihydrofolate to tetrahydrofolate, which is necessary for purine and thymidylate synthesis. This leads to impaired DNA synthesis in rapidly dividing cells like cancer cells.
Now, the other options might include other drugs that are not antifolates. For example, 5-fluorouracil is a pyrimidine analog, not an antifolate. Cytarabine is a nucleoside analog that inhibits DNA polymerase. Vincristine is a vinca alkaloid that affects microtubules. So, these are all different mechanisms.
The clinical pearl here is that methotrexate is a key antifolate used in various cancers, including leukemia and lymphoma. High-dose methotrexate requires leucovorin rescue to protect normal cells. Students should remember that antifolates target folate metabolism, distinct from other chemotherapeutic agents.
**Core Concept** Antifolate cancer drugs inhibit folate metabolism, a critical pathway for DNA synthesis. They target enzymes like **dihydrofolate reductase (DHFR)** or folate synthesis, selectively damaging rapidly dividing cells. Key examples include methotrexate, which is foundational in oncology and rheumatology.
**Why the Correct Answer is Right** Methotrexate is a classic antifolate that irreversibly inhibits DHFR, blocking the conversion of dihydrofolate to tetrahydrofolate. This disrupts purine and thymidylate synthesis, impairing DNA/RNA production in proliferating cells. It is used in malignancies like leukemia and solid tumors, and in autoimmune diseases at lower doses.
**Why Each Wrong Option is Incorrect**
**Option A:** *5-Fluorouracil* is a pyrimidine analog, not an antifolate; it inhibits thymidylate synthase.
**Option B:** *Cytarabine* is a nucleoside analog that inhibits DNA polymerase.
**Option C:** *Vincristine* is a vinca alkaloid that disrupts microtubule formation, unrelated to folate pathways.
**Option D:** *Cisplatin* is a platinum-based alkylating agent causing DNA cross-linking.
**Clinical Pearl / High-Yield Fact** Methotrexate requires **leucovorin rescue** at high doses to bypass its DHFR inhibition in normal cells. Remember: “Antifolates ≠ folates” (e.g., folinic acid is a folate supplement, methotrexate is its antagonist). Confusion with 5-fluorouracil (another antimetabolite) is common in exams.
**Correct Answer: D. Methotrexate**